 |
 A Journal Related to Head & Neck Oncology & Pathology
Editor:
Crispian Scully, CBE, Editorial Office:
See editorial board for all editors information
Description
Official journal of the European Association of Oral Medicine, International
Association of Oral Pathologists, and the International Academy of Oral Oncology.
The 2007 Impact Factor for Oral Oncology is 2.569, ranking it 65/132 in 'Oncology' and 6/51 in 'Dentistry, Oral Surgery
and Medicine' (courtesy Thomson Reuters).
ORAL ONCOLOGY: IMAGINE THE FUTURE
Second World Congress of the International
Academy of Oral Oncology
July 8 - 11 2009, Toronto, Canada
CALL FOR PAPERS
Abstract submission deadline: December
1 2008
Click here for more information!
Oral
Oncology
is an international interdisciplinary journal which publishes high quality original research, clinical trials and review
articles, and all other scientific articles relating to the etiopathogenesis, epidemiology, prevention, clinical features, diagnosis,
treatment and management of patients with neoplasms in the head and neck, and orofacial disease in patients with malignant disease.
Oral Oncology
is of interest to head and neck surgeons and oncologists, maxillo-facial surgeons, oto-rhino-laryngologists,
plastic surgeons, pathologists, scientists, oral medical specialists, special care dentists, dental care professionals, general practitioners,
general dental practitioners, public health physicians, palliative care physicians, nurses, radiologists, radiographers, dieticians,
occupational therapists, speech and language therapists, nutritionists, clinical and health psychologists and counselors, professionals
in end of life care, as well as others interested in these fields.
Research or Review papers of high quality and that make a
contribution to new knowledge are invited on the following aspects of neoplasms arising in the head and neck (including lip, tongue,
oral cavity, oropharynx, salivary glands, sinuses, nose, nasopharynx, larynx, skull base and craniofacial region, and the related hard
and soft tissues and lymph nodes) and craniofacial disease in patients with malignant disease:
• Etiopathogenesis: natural history
of cancer and pre-cancer; basic pathology, metastatic mechanisms; genetic changes; cellular and molecular changes; microorganisms; growth
factors, adhesion and other molecules
• Epidemiology; risk factors; biomarkers; protective factors; geographic factors; prevention;
screening and intervention
• Clinical features; orofacial effects of neoplasms at both local and distant sites; tumor staging
and grading
• Diagnosis; detection of cancer and pre-cancer; cellular and molecular markers for diagnosis; advances in imaging
and other functional diagnostic modalities for cancer and pre-cancer
• Management and Prognosis; clinical, cellular and molecular
markers for prognosis; treatment options including surgical, lasers, photodynamic therapy, cryosurgery, micro- vascular and other forms
of surgery, medical, radiotherapy, chemotherapy, immunotherapy, biological and gene therapy advances; molecular targets and new therapeutics
(new cytotonics and molecular-targeted therapies); multimodality treatment; advances in reconstruction and rehabilitation, including
flaps and grafts, alloplasty, bone and connective tissue biology; multidisciplinary teamwork in cancer care and oral health care.
•
Quality of life issues; issues of consent; psychosocial aspects; patient and health professional information; patient involvement; psychological
interventions, improving outcomes; the prevention, diagnosis and management of complications, including, pain, hemorrhage, dysfunction,
deformity, osteoradionecrosis, xerostomia, and others; rehabilitation; palliative and end of life care; and support teamwork.
•
Multicentre studies.
Bibliographic & ordering information
ISSN: 1368-8375
Imprint: PERGAMON
Subscriptions for the year 2009,
Volume 45,
12 issues
Institutional online access: ScienceDirect eSelect
For purchase of online access to this journal on ScienceDirect.
Personal price: Order form
EUR 155 for European countries and Iran
JPY 20,800 for Japan
USD 175 for all countries except Europe, Japan and Iran
Institutional price: Order form
EUR 1,252 for European countries and Iran
USD 1,398 for all countries except Europe, Japan and Iran
JPY 165,900 for Japan
Conditions of sale & ordering procedures, and links to our regional sales offices.
For an overview of recently-dispatched issues, see the Journal issue
dispatch dates
Combined subscriptions
European Journal of Cancer with Oral Oncology (Combined Subscription)
Impact factor of this journal
2007: 2.569
© Journal Citation Reports 2008, published by Thomson Reuters
063/631
Last update: 4 Sep 2008
|
|
| |
